Stock HTL HAMILTON THORNE LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hamilton Thorne Ltd. Toronto S.E.

Equities

HTL

CA4078911001

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E.
Other stock markets
 12:04:28 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.37 CAD +0.74% Intraday chart for Hamilton Thorne Ltd. +1.48% +3.01%
Mar. 27 Hamilton Thorne's Q4 Profit Falls, Sales Rise; Provides 2024 Outlook MT
Mar. 27 Hamilton Thorne Brief: 2024 guidance is for a sales range between US$78 and $82 million representing 10-15% organic growth; Q1 guidance is for a sales range of $19.0 to $19.4 million MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 101.7 152.2 231.7 174.1 152.4 152.9 - -
Enterprise Value (EV) 1 101.7 138.4 220.3 171.8 152.4 157.8 147.7 135.8
P/E ratio 80 x 110 x 81.5 x 120 x - 33.4 x 25 x -
Yield - - - - - - - -
Capitalization / Revenue 2.88 x 3.83 x 4.43 x 2.99 x 2.27 x 1.93 x 1.76 x 1.64 x
EV / Revenue 2.88 x 3.48 x 4.21 x 2.95 x 2.27 x 1.99 x 1.7 x 1.46 x
EV / EBITDA 14.3 x 21 x 22.5 x 17 x 13.2 x 9.96 x 8.03 x 6.13 x
EV / FCF 20.5 x 32.3 x 65.3 x -165 x 94.8 x 18.9 x 15.9 x 9.91 x
FCF Yield 4.88% 3.09% 1.53% -0.61% 1.05% 5.3% 6.3% 10.1%
Price to Book 2.63 x - 4.09 x 3.08 x - - - -
Nbr of stocks (in thousands) 127,141 138,515 142,242 144,832 151,863 152,758 - -
Reference price 2 0.8001 1.099 1.629 1.202 1.003 1.001 1.001 1.001
Announcement Date 4/22/20 4/8/21 4/7/22 3/30/23 3/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 35.36 39.78 52.35 58.18 67.23 79.27 86.74 93.2
EBITDA 1 7.096 6.608 9.773 10.09 11.52 15.84 18.39 22.15
EBIT 1 3.225 2.854 3.816 2.291 0.278 6.264 7.799 -
Operating Margin 9.12% 7.17% 7.29% 3.94% 0.41% 7.9% 8.99% -
Earnings before Tax (EBT) - 1.565 4.259 1.999 - - - -
Net income 1 0.7933 0.9712 2.434 1.911 -0.607 4.37 6.096 -
Net margin 2.24% 2.44% 4.65% 3.28% -0.9% 5.51% 7.03% -
EPS 2 0.0100 0.0100 0.0200 0.0100 - 0.0300 0.0400 -
Free Cash Flow 1 4.963 4.282 3.374 -1.043 1.607 8.367 9.3 13.7
FCF margin 14.04% 10.77% 6.44% -1.79% 2.39% 10.55% 10.72% 14.7%
FCF Conversion (EBITDA) 69.94% 64.8% 34.52% - 13.95% 52.83% 50.56% 61.85%
FCF Conversion (Net income) 625.62% 440.92% 138.61% - - 191.46% 152.57% -
Dividend per Share - - - - - - - -
Announcement Date 4/22/20 4/8/21 4/7/22 3/30/23 3/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 12.69 15.62 14.05 14.23 13.46 16.43 16.69 16.44 15.66 18.44 19.11 19.33 19.15 21.68 21
EBITDA 1 2.034 2.972 2.514 2.433 2.099 3.039 2.837 2.829 2.155 3.697 3.486 3.883 3.733 4.733 4.2
EBIT 0.4667 1.285 0.9609 1.535 -0.1626 0.917 0.4371 -0.3422 -0.7536 0.9366 - - - - -
Operating Margin 3.68% 8.23% 6.84% 10.78% -1.21% 5.58% 2.62% -2.08% -4.81% 5.08% - - - - -
Earnings before Tax (EBT) 1.133 1.237 0.8525 0.5004 -0.2377 0.884 0.1819 - - - - - - - -
Net income 0.2493 0.8365 0.5563 0.2745 0.0994 0.9804 0.0774 -0.4394 -0.7852 0.5402 - - - - -
Net margin 1.97% 5.35% 3.96% 1.93% 0.74% 5.97% 0.46% -2.67% -5.02% 2.93% - - - - -
EPS 2 - 0.0100 - - - - - - -0.0100 0.0100 0.003330 0.006670 0.0100 0.0133 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/22/21 4/7/22 5/19/22 8/23/22 11/22/22 3/30/23 5/15/23 8/17/23 11/13/23 3/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 4.9 - -
Net Cash position 1 - 13.8 11.4 2.26 - - 5.2 17.1
Leverage (Debt/EBITDA) - - - - - 0.3094 x - -
Free Cash Flow 1 4.96 4.28 3.37 -1.04 1.61 8.37 9.3 13.7
ROE (net income / shareholders' equity) 2.21% 2.16% 4.55% 3.41% -1.01% 5% 6% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 0.3000 - 0.4000 0.3900 - - - -
Cash Flow per Share 0.0400 - - - - - - -
Capex 1 - 0.59 2.23 2.84 2.38 4 - -
Capex / Sales - 1.49% 4.26% 4.89% 3.54% 5.05% - -
Announcement Date 4/22/20 4/8/21 4/7/22 3/30/23 3/27/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Hamilton Thorne Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.001 USD
Average target price
1.665 USD
Spread / Average Target
+66.33%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. HTL Stock
  4. HTL Stock
  5. Financials Hamilton Thorne Ltd.